Marc Buyse is the Founder of One2Treat, a company focused on evaluating treatment effects comprehensively. Marc also holds multiple titles at IDDI and CluePoints, where Marc uses their expertise in biostatistics. With a background in engineering and a ScD in Biostatistics from Harvard T.H. Chan School of Public Health, Marc has made significant contributions to the field across various roles in academia and industry.
Links
Previous companies
Org chart
This person is not in the org chart